Skip to main content

BARCLAYS PLC

Position in LCTX — Lineage Cell Therapeutics, Inc.

CIK 312069 LONDON, X0

Position in LCTX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$621,427
+$39,416 QoQ
Shares Held
393,309
+12.9% QoQ
Ownership
0.158%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2022
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LCTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

BARCLAYS PLC holds $1,494,072,071 across 362 Biotechnology names. LCTX ranks #135 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in LCTX

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $621,427 393,309
2025-12-31 $582,011 348,510
2025-09-30 $1 1
2025-06-30 $24,059 26,439
2025-03-31 $87,770 195,045
2024-12-31 $117,034 234,069
2024-09-30 $192,283 211,300
2024-06-30 $51,376 51,376
2024-03-31 $139,011 93,927
2023-12-31 $199,788 183,292
2023-09-30 $28,315 23,996
2023-06-30 $36,526 25,905
2023-03-31 $20,745 13,830
2022-12-31 $32,887 28,109
2022-09-30 $8,629 7,637
2022-03-31 $31,354 20,360